X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18121) 18121
Newsletter (279) 279
Newspaper Article (220) 220
Dissertation (137) 137
Magazine Article (128) 128
Book Chapter (103) 103
Conference Proceeding (25) 25
Book / eBook (8) 8
Web Resource (4) 4
Publication (2) 2
Book Review (1) 1
Journal / eJournal (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10433) 10433
male (6990) 6990
hypertension (6746) 6746
female (6463) 6463
hypertensive patients (4726) 4726
middle aged (4255) 4255
adult (3752) 3752
animals (3432) 3432
aged (3236) 3236
blood pressure (3005) 3005
peripheral vascular disease (2871) 2871
risk factors (2538) 2538
blood-pressure (2207) 2207
rats (2143) 2143
cardiac & cardiovascular systems (2070) 2070
hypertension - drug therapy (1901) 1901
pharmacology & pharmacy (1811) 1811
pregnancy (1710) 1710
hypertension - physiopathology (1552) 1552
blood pressure - drug effects (1546) 1546
antihypertensive agents - therapeutic use (1390) 1390
mortality (1355) 1355
spontaneously hypertensive-rats (1241) 1241
risk (1219) 1219
medicine, general & internal (1186) 1186
physiology (1152) 1152
health aspects (1149) 1149
preeclampsia (1149) 1149
research (1141) 1141
care and treatment (1123) 1123
hypertension - complications (1091) 1091
spontaneously hypertensive rats (1058) 1058
analysis (1028) 1028
cookery for hypertensives (1015) 1015
disease (1012) 1012
blood pressure - physiology (1009) 1009
treatment outcome (987) 987
diabetes (945) 945
hypertensive disorders (924) 924
medicine & public health (921) 921
urology & nephrology (896) 896
oxidative stress (888) 888
stroke (879) 879
aged, 80 and over (877) 877
diagnosis (877) 877
prospective studies (842) 842
prevalence (824) 824
rats, inbred shr (816) 816
medicine (814) 814
neurosciences (792) 792
obstetrics & gynecology (782) 782
endocrinology & metabolism (778) 778
cardiovascular disease (766) 766
cardiovascular diseases (762) 762
clinical neurology (756) 756
retrospective studies (756) 756
prevention (716) 716
cardiology (696) 696
time factors (690) 690
prognosis (676) 676
adolescent (675) 675
atherosclerosis (656) 656
management (654) 654
hypertensive-rats (650) 650
young adult (648) 648
drug therapy (646) 646
physiological aspects (640) 640
myocardial-infarction (629) 629
heart failure (625) 625
cardiovascular (621) 621
research article (603) 603
follow-up studies (588) 588
cardiovascular-disease (583) 583
risk-factors (575) 575
internal medicine (573) 573
angiotensin (572) 572
disease models, animal (570) 570
women (569) 569
rodents (568) 568
heart-failure (561) 561
heart (553) 553
expression (549) 549
case-control studies (547) 547
echocardiography (545) 545
left-ventricular hypertrophy (540) 540
magnetic resonance imaging (540) 540
surgery (535) 535
angiotensin-converting enzyme inhibitors - therapeutic use (532) 532
abridged index medicus (524) 524
nitric-oxide (519) 519
nitric oxide (512) 512
medicine, research & experimental (511) 511
pre-eclampsia (505) 505
rats, sprague-dawley (503) 503
studies (496) 496
hypertrophy (493) 493
hypertensive encephalopathy (491) 491
antihypertensive drugs (487) 487
arterial stiffness (486) 486
multidisciplinary sciences (486) 486
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17130) 17130
French (1628) 1628
Japanese (231) 231
German (221) 221
Russian (213) 213
Spanish (150) 150
Portuguese (84) 84
Korean (50) 50
Chinese (43) 43
Turkish (10) 10
Norwegian (9) 9
Hungarian (7) 7
Polish (7) 7
Czech (4) 4
Serbian (4) 4
Ukrainian (3) 3
Dutch (2) 2
Lithuanian (2) 2
Persian (2) 2
Arabic (1) 1
Belarusian (1) 1
Danish (1) 1
Italian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2020, Volume 382, Issue 17, pp. 1653 - 1659
Journal Article
Journal Article
Diabetes care, ISSN 1935-5548, 2013, Volume 36, Issue 11, pp. 3772 - 3778
... for cardiovascular morbidity and all-cause mortality in a cohort of 565 high-risk type 2 diabetic patients. RESEARCH DESIGN AND METHODS--Clinical, laboratory, ambulatory blood... 
ALL-CAUSE | EXPERT CONSENSUS DOCUMENT | INDEPENDENT PREDICTOR | PULSE-WAVE VELOCITY | ARTERIAL STIFFNESS | OLDER-ADULTS | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | AMBULATORY BLOOD-PRESSURE | STAGE RENAL-DISEASE | HYPERTENSIVE PATIENTS | Type 2 diabetes | Diabetics | Medical research | Care and treatment | Mortality | Brazil | Medicine, Experimental | Health aspects | Cholesterol | Original Research
Journal Article
Diabetologia, ISSN 1432-0428, 2011, Volume 55, Issue 3, pp. 566 - 578
...META-ANALYSIS Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis P... 
Angiotensin-converting enzyme inhibitors | Type 2 diabetes | End-stage renal disease | Human Physiology | Metabolic Diseases | Angiotensin receptor blockers | Internal Medicine | Systematic review | Meta-analysis | Albuminuria regression | Medicine & Public Health | Reno-protective effect | Doubling of serum creatinine | Macroalbuminuria | Microalbuminuria | Renin–angiotensin system blockade | Renin-angiotensin system blockade | FUNNEL PLOTS | COMBINATION THERAPY | MICROVASCULAR COMPLICATIONS | NEPHROPATHY | HYPERTENSIVE PATIENTS | MICROALBUMINURIA REDUCTION | CONVERTING ENZYME-INHIBITION | ENDOCRINOLOGY & METABOLISM | PLACEBO-CONTROLLED TRIAL | OUTCOMES | ENALAPRIL | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Angiotensin II - antagonists & inhibitors | Hypertension - drug therapy | Antihypertensive Agents - therapeutic use | Randomized Controlled Trials as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Kidney Failure, Chronic - prevention & control | Hypertension - complications | Adult | Renin-Angiotensin System - drug effects | Aged | Angiotensin Receptor Antagonists - therapeutic use | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Enzymes | Medical colleges | Diabetics | Care and treatment | Family medicine | Biometry | Enzyme inhibitors | Chronic kidney failure | Analysis | Calcium channel blockers | Angiotensin | Physiological aspects | Antihypertensive drugs | Public health | Meta-Analysis
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 3, pp. 251 - 260
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10085, pp. 2226 - 2237
.... Methods In this analysis, we assessed the previously reported outcome data from high-risk patients aged 55 years or older with a history of cardiovascular disease, 70... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | ONGOING TELMISARTAN | METAANALYSIS | RAMIPRIL | RATIONALE | DISEASE | TARGETS | COMBINATION | HYPERTENSIVE PATIENTS | ANTIHYPERTENSIVE TREATMENT | Benzoates - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Randomized Controlled Trials as Topic - methods | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Hospitalization - statistics & numerical data | Hypertension - drug therapy | Male | Multicenter Studies as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hypotension - mortality | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Cardiovascular Diseases - physiopathology | Antihypertensive Agents - therapeutic use | Hypotension - chemically induced | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Telmisartan | Hypotension - complications | Aged | Blood pressure | Hospitals | Research institutes | Germany | Myocardial infarction | Heart | Intervention | Syngeneic grafts | Funding | Clinical trials | Cardiovascular disease | Blood | Optimization | Risk factors | Clinical outcomes | Incidence | Recruitment | Peptidyl-dipeptidase A | Risk assessment | Failure analysis | Pretreatment | Heart diseases | Hypertension | Cerebral infarction | Stroke | Risk groups | Adjustment | Categories | Mortality | Regression analysis | Patients | Variance analysis | Oral cavity | Inhibitors | Converting | Angiotensin | Death | Fatalities | Infarction | Cardiovascular diseases | Health risk assessment | Heart attacks | Risk | Heart failure | Health risks | Coronary vessels | Diabetes | Mercury
Journal Article
Journal Article
Journal Article